The contrast agent makes the circulating blood column visible against surrounding tissues, allowing images to show vessel anatomy and blood flow. This enables assessment of whether vessels remain open, whether circulation follows the expected pathway, and whether an abnormal area still fills with contrast. These findings provide direct information about the vascular result of the operation.
Neurosurgical systems may use digital subtraction angiography or indocyanine green fluorescence to visualize vascular structures during an operation. Both support evaluation of vessel preservation and treatment results, but the overview does not specify that they provide identical image characteristics or require the same equipment. Their shared role is to supply vascular information before surgical closure.
Residual filling indicates that an abnormal vascular target may not be completely excluded from circulation. Detecting this finding while the operation is still underway gives the surgical team an opportunity to reassess the treatment rather than discovering the issue after closure. This is particularly relevant when evaluating cerebral aneurysms, arteriovenous malformations, or related cerebrovascular disorders.
The workflow begins by introducing a contrast agent into the circulation during surgery. The imaging system then acquires vascular images, which are examined for blood flow, vessel anatomy, patency, and abnormal residual filling. Clinicians use these findings to confirm the treatment result and guide decisions before completing and closing the operation.
Its main neuroscience applications include surgery for cerebral aneurysms, arteriovenous malformations, and other cerebrovascular disorders. In these settings, the technique helps clinicians determine whether the intended vascular lesion has been adequately treated while confirming that important surrounding vessels remain preserved. The information can therefore influence management during the same surgical procedure.
Clinicians can evaluate whether vessels remain patent, whether expected blood flow is present, and whether an aneurysm, arteriovenous malformation, or other abnormal vascular region continues to fill. This immediate assessment helps identify undetected vascular complications before closure, when findings can still guide surgical decisions and improve confidence in the completed treatment.